Aequus Pharmaceuticals Inc (AQS)

0.105
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.095/0.110
  • Day's Range:
    0.105 - 0.110
  • Type:Equity
  • Market:Canada
  • ISIN:CA0076361033
  • CUSIP:007636103

AQS Overview

Prev. Close
0.105
Day's Range
0.105-0.11
Revenue
2.7M
Open
0.11
52 wk Range
0.1-0.285
EPS
-0.01
Volume
0
Market Cap
13.93M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
31,875
P/E Ratio
-
Beta
0.54
1-Year Change
-34.37%
Shares Outstanding
132,634,431
Next Earnings Date
-
What is your sentiment on Aequus Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Aequus Pharmaceuticals Inc Company Profile

Employees
0
Market
Canada

Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company, which is focused on commercializing products in specialty therapeutic areas in the Canadian market. The Company is engaged in the sale of dry eye products and providing promotional services to sell third-party owned products. It is developing a pipeline of products in neurology and psychiatry with a focus on addressing the need for improved medication adherence through enhanced delivery systems. It intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide. The Company's sales and marketing efforts are based in Canada, targeting specialized therapeutic areas, including neurology, ophthalmology and transplant. Its Ophthalmology products include Evolve Intensive Gel, Evolve Daily Intensive, and Vistitan. Its Specialty products include Tacrolimus IR and Topiramate XR.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellSellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.